Photo from academic.microsoft.com
Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. Click to show full abstract
Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization.
Keywords:
thromboembolic events;
events five;
oral anticoagulants;
direct oral;
breakthrough venous;
venous thromboembolic
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!